WOONSOCKET, R.I., March 5, 2012 /PRNewswire/ -- CVS Caremark (NYSE: CVS) today announced that Troyen A. Brennan, MD, MPH, executive vice president and chief medical officer of the company, has been named to the National Commission on Physician Payment Reform, an independent commission that will assess how physicians are paid, and how pay incentives are linked to patient care.
The commission is sponsored by the Society of General Internal Medicine. The new panel is comprised of physicians, representatives from health care, insurance, a state health department, as well as health policy leaders and a consumer representative. Commission members will offer a range of perspectives in their efforts to provide a roadmap of cost-conscious payment changes that will help rein in health care spending while at the same time optimizing patient care.
The Commission will meet over the course of one year and issue recommendations in early 2013. The Commission is funded in part by the Robert Wood Johnson Foundation, the California Healthcare Foundation, and the Sergei Zlinkoff Fund for Medical Education and Research.
Before joining CVS Caremark in 2008, Brennan served as chief medical officer for Aetna Inc and president and CEO of Brigham and Women's Physicians Organization in Boston, MA. He is a member of the Institute of Medicine of the National Academy of Sciences. He has his MD and MPH from Yale Medical School, a JD from Yale Law School, a MA from Oxford University and a BS from Southern Methodist University, Texas. He has served on the faculties of Harvard Medical School, Harvard Law School and the Harvard School of Public Health.
About CVS Caremark
CVS Caremark is the largest pharmacy health care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are a pharmacy innovation company, uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 65,000 pharmacies, including more than 7,300 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's website at http://info.cvscaremark.com/.
SOURCE CVS Caremark